On June 22, CMS unveiled proposed guidance titled "Coverage with Evidence Development." Given AMCP's commitment to addressing health disparities in medication use and access, AMCP submitted comments in response to the proposed guidance on Aug. 21.
Health care expert Fred Goldstein sits down with Adam Colborn, director of government affairs at AMCP, to discuss AMCP’s federal policy priorities in the 118th Congress.
AMCP applauds the 10th Circuit for protecting the vital functions of ERISA & Medicare Part D, which provide essential services to workers and seniors, in yesterday’s ruling in the case of @PCMA v. Glen Mulready.
August 2023 Legislative & Regulatory Briefing: The Equitable Community Access to Pharmacist Services Act of 2023 is Introduced in the Senate; AMCP Hosts its First Virtual IRA Workshop; AMCP’s Adam Colborn Discusses PBM, Medicaid Best Price, and PDT Legislation; Register for the IRA Pre-Conference Program at Nexus 2023; Is Now the Time for Prescription Digital Therapeutics?
July 2023 Legislative & Regulatory Briefing: Tell Congress to Pass the MVP Act of 2023; AMCP Gathers PDT Manufacturers for Product Demonstrations on Capitol Hill; AMCP’s Adam Colborn Discusses Biosimilar Interchangeability with AJMC; Register for the Inflation Reduction Act Pre-Conference Program at AMCP Nexus 2023; Catch Up on the Latest Regulatory NewsBREAKs.
